The applicant presented detailed data on risk assessment, criticality of each step of manufacture using FailureMode Effect Analysis (FMEA) and high resolution design of experiments (DoEs) for steps 1 and 2 and substeps 3 along with their statistical analyses. Both the critical and noncritical process parameters were clearlyidentified alongside their ranges. The conclusions of these DoEs generally support the ranges of criticalprocess parameters (CPPs) and non CPPs described. Based on the studies, design spaces have beenproposed for step 1 and step 3 of the synthesis. The design spaces were established with lab scale batches.For the steps which are not part of the design space, proven acceptable ranges have been specified. Theactive substance critical quality attributes (CQAs) and the control strategy have been adequately described.